Transportation in US and Singapore, 1 deal in Industrial, 1 deal in Hi-tech and 3 deals in Medical). However, weakness in semiconductor space is likely to dent growth prospects. EBITDA margin at 18.5% (excl. IND AS impact) was ahead of estimates (Ple: 17.2%; consensus: 17.8%)....